@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4> .
@prefix sub: <http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=> .
@prefix ns1: <https://uts.nlm.nih.gov/uts/umls/concept/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubInfo ;
    a np:Nanopublication .
}
sub:assertion {
   sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
  sub:version prov:value 1 .
  rdf:object ns1:C1947944 "use" ;
    ns1:C5383282 "convalescent plasma therapy" .
  rdf:predicate ns2:TRIPLE_UID:fv8lr3bm-TRIPLE-ABSTRACT-11 "call" .
  rdf:subject ns1:C0003241 "antibody" ;
    ns1:C0005841 "transfusion" ;
    ns1:C0011777 "dexamethasone" ;
    ns1:C0021027 "antibody" ;
    ns1:C1167408 "antibody" ;
    ns1:C1621287 "antibody" ;
    ns1:C1879316 "transfusion" ;
    ns1:C3665580 "antibody" ;
    ns1:C5203670 "COVID-19" .
  rdfs:Triple-UID ns3:TRIPLE_UID:fv8lr3bm-TRIPLE-ABSTRACT-11 "fv8lr3bm-TRIPLE-ABSTRACT-11" .
  rdfs:sentence rdfs:label "Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus is responsible for the current pandemic - coronavirus disease 2019 (COVID)-19) plaguing the world Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus began spreading as early as January 2020 in the United States (US) and has recently become the leading cause of death amongst adults over 45 years of age Much of Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus's clinical presentation is already known, and there have been advances in Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus's successful treatment with a food and drug administration (FDA) approved antiviral medication called remdesivir, and other proven investigational methods with clinical benefits including dexamethasone and Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus antibody transfusion called convalescent plasma therapy However, the recommendations for other proven investigational methods with clinical benefits including dexamethasone and COVID-19 antibody transfusion called convalescent plasma therapy's use include COVID-19 confirmed patients requiring supplemental oxygen or other forms of respiratory support In this case report, we describe in detail a unique case of severe Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus infection that did not require any form of oxygen support hut was treated successfully with antiviral medications and steroids The purpose of this case report is to highlight in detail an unusual Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus presentation with rhabdomyolysis, myocarditis, and pancytopenia severe enough to require hospitalization and treatment with proven Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus therapy to achieve clinical resolution" .
  rdfs:triple rdfs:label "dexamethasone and COVID-19 antibody transfusion called convalescent plasma therapy s use" .
}
sub:provenance {
   sub:assertion prov:generatedAtTime "2021-07-25T21:47:44.864391"^^xsd:dateTime .
}
sub:pubInfo {
   sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" ;
    npx:hasSignature "GlZA70ScsPN63HJ5hL65ON/Gg1tCXHstoPc37eO3NjZswFlYu6CIOp6XzBctxIBqDEHskPkp6Lvx5ljJ8M8jcUJxhJAHVGDamm8Hz9cCo6KdsEWcKsHz2eH0pOXqrtc0sNMjGbHTe8B58WzctRMVIk0fTMd4ro35ZIQaZeqyeUA=" ;
    npx:hasSignatureTarget this: .
  this: prov:generatedAtTime "2021-07-25T21:47:44.864391"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}